This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Review -
Endocrine disruptors and estrogenic effects on male reproductive axis
Suresh C. Sikka, Run Wang
1Department of Urology, Tulane University Health Sciences Center, New Orleans, LA 70112-2699, USA
2Departments of Urology, University of Texas Medical School at Houston and University of Texas MD Anderson Cancer
Center, Houston, TX 77030, USA
Abstract
Endocrine disruptors (e.g., polychlorinated biphenyls [PCBs], dichlorodiphenyl-trichloroethane [DDT], dioxin,
and some pesticides) are estrogen-like and anti-androgenic chemicals in the environment. They mimic natural hormones,
inhibit the action of hormones, or alter the normal regulatory function of the endocrine system and have potential
hazardous effects on male reproductive axis causing infertility. Although testicular and prostate cancers, abnormal
sexual development, undescended testis, chronic inflammation, Sertoli-cell-only pattern, hypospadias, altered
pituitary and thyroid gland functions are also observed, the available data are insufficient to deduce worldwide conclusions.
The development of intra-cytoplasmic sperm injection (ICSI) is beyond doubt the most important recent
breakthrough in the treatment of male infertility, but it does not necessarily treat the cause and may inadvertently pass on
adverse genetic consequences. Many well-controlled clinical studies and basic scientific discoveries in the physiology,
biochemistry, and molecular and cellular biology of the male reproductive system have helped in the identification of
greater numbers of men with male factor problems. Newer tools for the detection of Y-chromosome deletions have
further strengthened the hypothesis that the decline in male reproductive health and fertility may be related to the
presence of certain toxic chemicals in the environment. Thus the etiology, diagnosis, and treatment of male factor
infertility remain a real challenge. Clinicians should always attempt to identify the etiology of a possible testicular
toxicity, assess the degree of risk to the patient being evaluated for infertility, and initiate a plan to control and prevent
exposure to others once an association between occupation/toxicant and infertility has been
established. (Asian J Androl 2008 Jan; 10: 134_145)
Keywords: endocrine disruptors; environmental estogens; hypothalamic-pituitary-testicular axis; oxidative stress; male infertility
Correspondence to: Dr Suresh C. Sikka, Faculty of Cancer Center Consortium, Molecular & Cell Biology and Center of Bioenvironmental
Research Programs, Tulane University Health Sciences Center, 1430 Tulane Ave., SL-42 , New Orleans, LA 70112-2699, USA.
Tel: +1-504-988-5179 Fax: +1-504-988-5059
E-mail: ssikka@tulane.edu
DOI: 10.1111/j.1745-7262.2008.00370.x
1 Introduction
Endocrine disruptors are estrogen-like and/or anti-androgenic chemicals in the environment that have potentially
hazardous effects on male reproductive axis resulting in infertility and on other hormonal dependent reproductive
functions causing erectile dysfunction (ED). These chemicals are called
"endocrine disruptors" because they (i)
mimic natural hormones, (ii) inhibit the action of hormones, and/or (iii) alter the normal regulatory function of the
endocrine systems. Besides reduced fertility and ED, testicular and prostate cancers, abnormal sexual development,
alteration in pituitary and thyroid gland functions, immune suppression, and neurobehavioral effects are also possible
due to such endocrine disruption in the male.
Data collected over the last 30 years have shown disturbing trends in male reproductive health. An earlier report
from Scotland revealed that men born after 1970 had a sperm coun
t 25% lower than those born before 1959_an
average decline of 2.1% a year [1]. The lower sperm count was also associated with poor semen quality [2]. In
contrast, Olsen et al. [3], used several statistical models and found an actual increase in average sperm numbers.
Thus, while some environmentalists believe that the human species is approaching a fertility crisis, others think that
the available data are insufficient to deduce worldwide
conclusions [4, 5]. Newer tools for the detection of
Y-chromosome deletions have strengthened the hypothesis
that the decline in male reproductive health and fertility
may be related to the presence of certain toxic chemical
compounds in the environment [6]. These chemicals
mimic or otherwise disrupt the estrogens or the
androgen balance in the body by binding to hormone receptors
during fetal and neonatal development and give rise to
reproductive abnormalities, including low sperm counts
in adulthood. Because of these effects, such endocrine
disruptors are also popularly known as "gender
benders". With discoveries of deformed frogs in Minnesota lakes
and fertility problems in alligators found in Lake Apopka
in Florida [7] attributed to embryonic exposure to
pollutants, a myriad of environmental agents have been
classified as male reproductive toxicants. This has been
the subject of a number of reviews [8_12], suggesting
that etiology, diagnosis, and treatment of male factor
infertility remains a real challenge. However, the evidence
that such environmental chemicals cause infertility is still
largely circumstantial. There are many missing links in
the causal chain that would connect receptor binding to
changes in reproductive health with decreased fertility.
The fact remains that one in six couples have trouble
conceiving, with males equally responsible for their
infertility. The most important recent breakthrough in
the treatment of male infertility was the development of
intra-cytoplasmic sperm injection (ICSI). This was
made possible by many well-controlled clinical studies
and basic scientific discoveries in the physiology,
biochemistry, and molecular and cellular biology of the
male reproductive system.
2 Background
Many environmental xenobiotic chemicals, such as
polychlorinated biphenyls (PCBs),
dichlorodiphenyl-trichloroethane (DDT), dioxin, and some pesticides have
estrogenic effects [13_15]. Dibromochloropropane (DBCP) exposure impaired fertility in the absence of any
other clinical signs of toxicity, suggesting that the male
reproductive system was the most sensitive target organ.
The potential hazards these chemicals may have on
human health and ecological well-being include
reproductive tract cancers, reduced fertility, embryo/fetal loss,
birth defects, childhood cancer, other postnatal
structural or functional problems, and abnormality in sexual
development [14, 16_17].
However, the database for establishing safe
exposure levels or risk assessment for such outcomes
remains very limited. Declining semen quality is not the
only indicator that suggests that human reproduction is
at risk. A marked increase in the incidence of testicular
cancer in young men has been associated with other
abnormalities (including undescended testis,
Sertoli-cell-only pattern, and hypospadias) which cause poor
gonadal function and low fecundity rates.
The human male produces relatively fewer sperm on
a daily basis compared with many of the animal species
used for toxicity testing [18]. In fact, in many men over
age 30, the lower daily sperm production rate already
places them close to the subfertile or infertile range
[18,19]. A less dramatic decrease in sperm numbers, motility,
and/or morphology in humans can have serious
consequences for reproductive potential, even though it takes
only one sperm to fertilize an egg. Problems in the
production, maturation, and fertilizing ability of sperm
are the single most common cause of male infertility.
Although any discussion of gonadal function and
toxicity is of special relevance to man, much of this
understanding has been obtained from various experimental
models and research using animal species. In addition,
both intra-testicular and post-testicular events have been
postulated and different mechanisms have been proposed
to explain the presence of damaged DNA in human spermatozoa. Three among them, i.e. abnormal
chromatin packaging, oxidative stress and apoptosis, are the
most studied [20]. Higher levels of DNA damage means
that sperm are less likely to undergo apoptosis which is a
natural self-destruct process designed to rid the body of
damaged cells. However, it is not clear whether increased
damage arises because of chronological age or because
of longer-term exposure to environmental factors that
may cause such damage.
3 Male reproductive tract target sites
An endocrine disruptor can effect several potential
target sites in the male reproductive tract. The most
important being the testes, the male gonads, which
usually exist in pairs and are the sites of spermatogenesis
and androgen production. There are paracrine and autocrine regulations in various compartments of the testis
that are under endocrine influences from the pituitary
and hypothalamus. About 80% of the testicular mass
consists of highly coiled seminiferous tubules within which
spermatogenesis takes place. The remaining 20%
consists of Leydig cells and Sertoli cells, whose main job is
to establish normal spermatogenesis. Spermatozoa are
the haploid germ cells responsible for fertilization and
species propagation.
3.1 Sertoli cells
Within the testes are Sertoli cells, or "nurse cells,"
that form a continuous and complete lining within the
tubular walls which envelope the developing sperm
during spermatogenesis. These cells establish the
blood-testis barrier by virtue of tight junctions. The luminal
environment as controlled by these Sertoli cells is under
the influence of follicle stimulating hormone (FSH) and
inhibin. These Sertoli cells:
(1) provide nourishment for the developing sperm
cells;
(2) destroy defective sperm cells;
(3) secrete fluid that helps in the transport of sperm
into the epididymis;
(4) release the hormone inhibin that helps regulate
sperm production.
The differentiation of Sertoli cells and the formation
of a competent blood-testis barrier are essential to the
establishment of normal spermatogenesis during puberty.
Thus, many irregularities of spermatogenesis due to
interference by endocrine disruptors may reflect
changes in the function of the Sertoli cell population
and not necessarily by pathology in the germ cells
themselves.
3.2 Leydig cells
Leydig cells are the endocrine cells in the testis that
produce testosterone from cholesterol via a series of
enzymatic pathways and steroidal intermediates under
the control of luteinizing hormone (LH) from the pituitary.
These cells arise from interstitial mesenchymal tissue
between the tubules during the eighth week of human
embryonic development. They are located in the connective
tissue between the seminiferous tubules.
3.3 Spermatogenesis
Spermatogenesis is a chronological process spanning about 80 days in man and 40_50 days in the rodent
(depending upon species). During this period, the
immature germ cells (relatively undifferentiated
spermatogonia), develop into highly specialized spermatozoa in a
cyclic manner. Spermatogonia undergo several mitotic
divisions to generate a large population of primary
spermatocytes, which produce haploid spermatids by two meiotic
cell divisions. Spermiogenesis is the transformation of
spermatids into elongated flagellar germ cells capable of
motility. The release of mature germ cells is known as
spermiation. Most of the testicular volume, which
diminishes if testicular damage has occurred, consists of
these germ cells,. During mitotic arrest, the gonocyte
becomes acutely sensitive to toxic agents. Low-dose
irradiation, e.g., may completely eradicate germ cells while
causing little damage to developing Sertoli cells, thus
creating a Sertoli-cell-only testes [21].
4 Role of endocrine disruption in male reproduction
Many estrogenic pollutants (endocrine disruptors),
including agricultural products (phytoestrogens),
industrial chemicals and heavy metals have significant
reproductive consequences due to their multiple routes of
exposure, their widespread presence in the environment,
and their ability to bioaccumulate and resist biodegradation.
In addition, many pharmacological and biological agents
including radiation therapy affect male reproduction by
disrupting hormonal balance (Table 1) as described below.
4.1 Environmental agents
4.1.1 Agricultural and industrial chemicals
A detrimental effect of agricultural and industrial
chemicals on sperm concentration, motility, and
morphology may be caused by impaired spermatogenesis
secondary to various hormonal alterations [22].
Abnormal sperm morphology due to secretory dysfunction of
the Leydig and Sertoli cells may impair the
sperm-fertilizing capacity. Agricultural chemicals implicated in male
reproductive toxicity include DDT (o,p-DDT),
epichlorhydrin, ethylene dibromide, kepone, and dioxin
[23]. DBCP, a nematocide widely used in agriculture, is a
testicular toxicant that induces hypergonadotropic
hypogonadism [24]. DDT, a commonly used pesticide, and its
metabolites (p,p'-DDT, and p,p'-DDE) have estrogenic
effects in males by blocking the androgen receptors [22,
23, 25]. Polycyclic aromatic hydrocarbons (PAHs) are
ubiquitous undefined complex mixtures encountered in
the environment because of industrial combustion and
excessive use of tobacco products [26]. Methyl chloride,
an industrial chemical, used in the production of organosilicates and gasoline antiknock additives has been
extensively studied. Such organic solvents have been
reported to induce changes in semen quality, testicular
size, and serum gonadotropins [27]. Exposure to
persistent organochlorine pollutants has been associated
with human perturbations of the sperm X:Y chromosome ratio [6].
The levels of serum free/bound toxicant will
influence the androgen-blocking capacity. The
plasma/tissue concentration of an estrogenic toxicant depends upon
the detoxification and elimination mechanisms in the
organism. The fate and detoxification of these
organochemicals have not been well defined, but these agents
can disrupt the hypothalamic-pituitary-testicular axis
affecting the endocrine and reproductive functions. Since
environmental exposure is due to a mixture of various
endocrine disruptors, the effect of their combined
toxicity becomes more important. However, the long-term
effects of such exposure, especially at low dose, on male
reproductive axis and fertility have not been examined in
detail in a well-designed study.
4.1.2 Heavy metals
Heavy metals (e.g., arsenic, lead, boron, mercury,
cadmium, antimony, aluminum, cobalt, chromium, lithium) have
been found to exert adverse effects on the reproductive
axis of human and experimental animals. More reports
are available on lead-induced toxicity than any other heavy
metal. Historically, the fall of the Roman Empire has
been attributed to lead poisoning [28]. Men working in
battery plants and exposed to toxic levels of lead
demonstrated adverse effects on their reproductive capacity
[29,30]. In animals, lead exposure results in a
dose-dependent suppression of serum testosterone and
spermatogenesis [31, 32]. Although testicular biopsies reveal
peritubular fibrosis, vacuolation, and oligospermia,
suggesting that lead is a direct testicular toxicant [33], some
mechanistic studies show that lead exposure can disrupt
the hormonal feed-back mechanism at the
hypothalamic-pituitary level [9]. Animal studies suggest that these
effects can be reversed when lead is removed from the
system. Such detailed evaluations in humans need
further investigation.
Boron is extensively used in the manufacture of glass,
cements, soaps, carpets, crockery, and leather products.
Oligospermia and decreased libido were reported in men
working in boric acid-producing factories [34]. Boron
has a major adverse reproductive effect on the testes
and the hypothalamic-pituitary axis in a manner similar
to lead toxicity. Cadmium, another heavy metal, is a
testicular toxicant that is used widely in industries like
electroplating, battery electrode production, galvanizing,
plastics, alloys, paint pigments [35]. It is also present in
soil, coal, water, and cigarette smoke. In animal studies,
cadmium has been shown to cause severe testicular
necrosis in mice that is also strain-dependent [36].
Cadmium-DNA binding and inhibition of
sulfhydryl-containing proteins mediate cadmium toxicity directly or through
transcription mechanisms. It can also induce the
expression of heat shock proteins, oxidative stress response
genes, and heme oxygenase induction mechanisms [37].
Clinical studies have associated cadmium exposure with
testicular toxicity, altered libido, and
infertility. Further studies are needed to delineate the specific gonadotoxic
mechanisms involved in cadmium induced reproductive
toxicity. Mercury exposure can happen during the
manufacture of thermometers, thermostats, mercury vapor
lamps, paint, electrical appliances, and in mining. Such
exposure can alter spermatogenesis and has been found
to decrease fertility in experimental animals.
4.2 Biological factors
Chronic disease states, aging, toxin exposure,
physical injury, and exposure to many types of environmental
contaminants enhance specific biological activity leading
to hyperthermia and increased free radical generation
leading to oxidative stress that can cause gonadal and
gamete damage [38]. In addition, the generation of nitric
oxide (NO) radicals and reactive nitrogen species (RNS)
has recently been found to have an astounding range of
biological influences_including vascular tone,
inflammation with increased cytokines, and as a mediator of many
cytotoxic and pathological effects [39]. NO generation
in response to toxic exposure associated with hormonal
imbalance can contribute to poor sperm motility and
function leading to infertility [40].
4.3 Pharmacological agents
Radiation therapy and many pharmacologic drugs and
chemotherapeutic agents are known to adversely affect
male reproduction (Table 1).
4.3.1 Radiation
Radiation exposure (X-rays, neutrons, and
radioactive materials) induces testicular damage that is generally
more severe and difficult to recover than that induced by
chemotherapy. Radiation effects on the testes depends
upon the dose, number of doses and the duration of the
delivered irradiation, as well as the developmental stage
of the germ cell in the testes at the time of exposure
[41]. Radiotherapy that is used as an alternative therapy
for the treatment of seminomatous germ cell tumors and
lymphomas can be gonadotoxic. In general, germ cells
are the most radiosensitive. A direct dose of irradiation
to the testes greater than 0.35 Gy causes aspermia. The
time taken for recovery of the germinal epithelium
increases with larger doses, and doses in excess of 2 Gy
will likely lead to permanent azoospermia. At higher
radiation doses (> 15 Gy), Leydig cells will also be
affected [42]. Vulnerability of the testis to irradiation
depends upon the age and the pubertal status of the male.
In addition to direct damage to the testes, whole body
irradiation can also damage the hypothalamic-pituitary
axis and affect reproductive capability [43].
4.3.2 Drugs and phytoestrogens
Many synthetic pharmacological agents, phytoestrogens and anabolic steroids affect normal endocrine
functions. The use/abuse of these anabolic steroids mainly
among athletes has grown to epidemic proportions. This
has resulted in severe oligozoospermia and decreased
libido. The hypogonadotropic hypogonadism due to
feedback inhibition of the hypothalamus-pituitary axis is the
most common cause of severe impairment of normal sperm production in this population [44]. These defects
can be reversed within four months of discontinuation;
however, sporadic azoospermia has been reported in some
young men even one year after cessation of chronic
anabolic steroid use [45].
4.3.3 Chemotherapeutic agents
As early as 1954, antibacterial agents were reported
to be toxic to spermatozoa [46]. Antibiotics and cancer
chemotherapy usually damages the germinal epithelium
[47, 48]. Mechlorethamine, extensively used as
nitrogen mustard during the second world war, causes
spermatogenic arrest [49]. Many common cytotoxic agents
cause a dose-dependent progressive decrease in sperm
count, leading to azoospermia [50]. Postmeiotic germ
cells are specifically sensitive to cyclophosphamide
treatment, with abnormalities observed in progeny [51].
Chronic low-dose cyclophosphamide treatment in men
may affect the decondensation potential of spermatozoa
due to the alkylation of nuclear proteins or DNA. This is
likely to affect pre- and post-implantation loss or
contribute to congenital abnormalities in offspring [52].
Combination therapy with alkylating agents has been
shown to improve survival in the treatment of Hodgkin's
disease, lymphoma, and leukemia. However, such
combination therapy has induced sterility in most adults, as
revealed by complete germinal aplasia in testicular
biopsy specimens [53]. Many antimicrobials (e.g.,
tetracycline derivatives, sulfa drugs, nitrofurantoin, and
macrolide agents, like erythromycin) impair spermatogenesis
and sperm function [46, 47].
In general, the severity of testicular damage is
related to the category of chemotherapeutic agent used,
the dose and duration of therapy, and the developmental
stage of the testis. The recovery of spermatogenesis is
variable and depends upon the total therapeutic dose and
duration of treatment [54]. The effects of cytotoxic drugs
on the testicular function of children are inconclusive,
due to the relative insensitivity in detecting such damage
with available technology; however, the prepubertal and
adolescent testes show damage to a lesser extent by
chemo- and radiation therapy than the postpubertal or
older testis [41]. This may be due to rapid turn-over
and recovery of damaged cells by active spermatogenesis in younger gonads. The use of testicular biopsy,
semen analysis, and assessment of the
hypothalamic-pituitary-gonadal (HPG) axis can commonly achieve the
evaluation of testicular toxicity.
5 Mechanism(s) of action of endocrine disruptions
on HPG axis
Complex interactions are involved in normal gonadal
function and hormonal communication. There are
multiple loci that could be involved mechanistically in a
toxicant's endocrine-related effects. Impairment of such
hormonal control could occur as a consequence of
altered hormone biosynthesis, storage/release and
transport/clearance, receptor recognition/binding, and/or
post-receptor responses.
5.1 Altered hormone bio-synthesis
A number of agents possess the ability to inhibit the
biosynthesis of various hormones. Some of these agents
inhibit specific enzymatic steps in the biosynthetic pathway
of steroidogenesis (e.g., aminoglutethimide, cyanoketone,
ketoconazole). Some fungicides block estrogen
biosynthesis by inhibiting aromatase activity that converts
testosterone to estrogen in the testis. Environmental
estrogens and antiandrogens further alter protein biosynthesis
induced by gonadal steroids through a series of signals
at transcriptional and translational levels [55].
Both estrogen and testosterone have been shown to affect
pituitary hormone synthesis directly or through changes in the
glycosylation of LH and FSH [56]. A decrease in glycosylation of these glycoproteins reduces the
biological activity of the hormones. Any environmental
compound that mimics or antagonizes the action of these
steroid hormones could presumably alter glycosylation.
5.2 Altered hormone storage and/or release
Steroid hormones do not appear to be stored
intracellularly within membranous secretory granules. For
example, testosterone is synthesized by the Leydig cells
of the testis and released on activation of the LH receptor.
Thus, compounds that block the LH receptor or the
activation of the 3',5'-cyclic AMP (cAMP) dependent
cascade involved in testosterone biosynthesis can rapidly alter
the secretion of this hormone. The release of many protein
hormones is dependent on the activation of second
messenger pathways, such as cAMP, phosphatidylinositol
4,5-bisphosphate (PIP2), inositol 1,4,5-trisphosphate
(IP3), tyrosine kinase, including
Ca2+ channels. Interference with these processes consequently will alter the
serum levels (bioavailability) of many hormones. Several
metal cations have been shown to disrupt pituitary
hormone release presumably by interfering with
Ca2+ flux [57].
5.3 Altered hormone transport and clearance
Hormones are transported from blood in the free or
bound state. Steroid hormones are transported in the
blood by specialized transport (carrier) proteins known
as steroid hormone-binding globulin (SHBG) or
testosterone-estrogen-binding globulin (TEBG). Regulation of
the concentration of these binding globulins in the blood
is of clinical significance because either increases or
decreases in their level could affect steroid hormone
bioavailability. For example, DDT analogs that are
potent inducers of hepatic microsomal monooxygenase
activities in vivo [58], could cause a decrease in
transport of testicular androgen as a result of enhanced
degradation. Similarly, treatment with lindane
(gamma-hexachlorocyclohexane) has been reported to increase
the clearance of estrogen [59].
5.4 Altered hormone receptor recognition/binding
Hormones elicit responses from their respective
target tissues through direct interactions with either
intracellular receptors or membrane-bound receptors.
Specific binding of the natural ligand to its receptor is a
critical step in hormone function. Intracellular (nuclear)
receptors, such as those for sex steroids, adrenal steroids,
thyroid hormones, vitamin D, and retinoic acid, regulate
gene transcription in a ligand-dependent manner through
their interaction with specific DNA sequences termed
response elements. A number of environmental agents
may alter this process by mimicking the natural ligand
and acting as an agonist or by inhibiting binding and
acting as an antagonist. The best known examples are
methoxychlor, chlordecone (Kepone), DDT, some PCBs,
and alkylphenols (e.g., nonylphenols and octylphenols),
which can disrupt estrogen receptor function [60, 61].
The antiandrogenic action of the dicarboximide
fungicide vinclozolin is the result of an affinity of this
compound's metabolites for the androgen receptor [16].
Interestingly, the DDT metabolite p, p'-DDE has been
found to bind also to the androgen receptor and block
testosterone-induced cellular responses in
vitro [25].
Many of the chemicals classified as environmental
estrogens can actually inhibit binding to more than one
type of intracellular receptor. For example, o,p-DDT
and chlordecone can inhibit endogenous ligand binding
to the estrogen and progesterone receptors, with each
compound having IC50s that are nearly identical for the
two receptors. Receptors for protein hormones are
located on and in the cell membrane. When these
hormones bind to their receptors, transduction of a signal
across the membrane is mediated by the activation of
second messenger systems. These may include (a)
alterations in G-protein/cAMP-dependent protein kinase A
(e.g., after LH stimulation of the Leydig cell), (b)
phosphatidylinositol regulation of protein kinase C, and
inositol triphosphate (e.g., after GnRH stimulation of
gonadotrophs; thyrotropin releasing hormone stimulation
of thyrotrophs), (c) tyrosine kinase (e.g., after insulin
binding to the membrane receptor), and (d) calcium ion
flux. Xenobiotics thus can disrupt signal transduction
of peptide hormones if they interfere with one or more
of these processes.
5.5 Altered hormone post-receptor activation
Once the endogenous ligand or an agonist binds to
its receptor, a cascade of events is initiated indicative of
the appropriate cellular response. This includes the
response necessary for signal transduction across the
membrane, or in the case of nuclear receptors, the
initiation of transcription and protein synthesis. A variety of
environmental compounds can interfere with the membrane's second messenger systems. For example,
cellular responses that are dependent on the flux of calcium
ions through the membrane (and the initiation of the
calcium/Calmodulin dependent cellular response) are altered
by a variety of environmental toxicants. Interestingly,
the well-known antiestrogen tamoxifen inhibits protein
kinase C activity while the phorbol esters are known to
mimic diacylglycerol and enhance protein kinase C
activity [62].
Steroid hormone receptor activation can be modified
by indirect mechanisms, such as a down-regulation of
the receptor (temporary decreased sensitivity to ligand)
as seen after 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin
(TCDD) exposure (including the estrogen, progesterone,
and glucocorticoid receptors) [63]. Consequently,
because of the diverse known pathways of endocrine
disruption, any assessment must consider the net result
of all influences on hormone receptor function and
feedback regulation.
5.6 Induction of oxidative stress
"Oxidative stress" is a condition associated with an
increased rate of cellular damage induced by oxygen and
oxygen-derived free radicals commonly known as
reactive oxygen species (ROS). In addition, the generation
of NO radicals and RNS has recently been found to
mediate many physiologic, cytotoxic and pathological
effects [39]. NO generation in response to toxic exposure
may be associated with hormonal imbalance that can
contribute to poor sperm motility and function leading to
infertility [40]. Also, NO and superoxide radicals can
combine to form highly reactive peroxynitrite radicals,
which induce endothelial cell injury [64]. This may
result in altered blood flow to the testis and may impair
testicular function.
The assumption that free radicals can influence male
fertility has received substantial scientific support [65].
The proposed mechanism for loss of testicular and sperm
function due to oxidative stress has been shown to
involve excessive generation of ROS [66]. Free radicals
can damage DNA and proteins, either through oxidation
of DNA bases (primarily guanine via lipid peroxyl or
alkoxyl radicals) or through covalent binding resulting in
DNA strand breaks and cross-linking [67]. ROS can
also induce oxidation of critical-sulfa-hyroxyl (SH) groups
in proteins and DNA, which will alter cellular integrity
and function with an increased susceptibility to attack
by toxicants. Oxidative stress is theoretically the result
of an improper balance between ROS generation and
intrinsic scavenging activities. Adequate levels of
superoxide dismutase (SOD), catalase, and probably
glutathione (GSH) peroxidase and reductase normally
maintain the free radical scavenging potential in the testes.
This balance can be referred to as oxidative stress status
(OSS), and its assessment may play a critical role in
monitoring testicular toxicity and infertility [10].
6 Evaluation of male reproductive toxicity
Several methods are being evaluated for the
assessment of the effects of toxicants on the male
reproductive system (Table 2). Essentially, any risk assessment
usually has four components: (1) hazard identification,
(2) dose-response assessment, (3) human-exposure assessment, and (4) risk characterization. The hazard
identification and dose-response data are developed from
experimental animal studies that may be supplemented
with data from in vitro studies. This information is then
extrapolated and integrated to characterize and assess
the risk to the human population. Table 2 lists how such
effects of endocrine disruptors and other toxicants on
specific components of HPG axis can be evaluated using
both in vivo and in vitro tools.
6.1 In vivo systems
In vivo methods are important tools to study the
integrated male reproductive system. The complete
in vivo assessment of testicular toxicity involves
multigenerational studies, now required by most regulatory agencies.
These multigenerational studies have a complex design,
because testicular function and spermatogenesis are very
complicated processes. The spermatogenic cycle is
highly organized throughout the testis. In the rat, it
requires about 50 days. If a toxicant affects the immature
spermatogonia, the effect may not be detectable as a
change in mature sperm before 7 to 8 weeks. Effects on
more mature germ cells would be detected sooner. To
test the sensitivity of all stages of spermatogenesis, the
exposure should last the full duration of the cycle. This
cannot be achieved in vitro, because germ cell
differentiation and the physical relationship of stages within the
tubules are lost in cell culture systems. The germ cells
are entirely dependent upon the Sertoli cells for physical
and biochemical support. Complicated endocrine and
paracrine systems control Sertoli cells, Leydig cells, and
germ cells. Besides the loss of paracrine interactions,
the altered metabolic activity of target or adjacent cells
and difficulty in isolating and testing certain
spermatogenic stages are other significant limitations of
in vitro assessment of testicular toxicity [68]. In addition, for
accurate identification of stage-specific lesions of the
seminiferous epithelium, critical evaluation of
morphological structures is very important. Because germ cells are
continuously dividing and differentiating, the staging of
spermatogenesis has proven to be an extremely sensitive
tool to identify and characterize even subtle toxicological
changes.
The most common approach to evaluate the effect
of cytotoxic drugs on the testis in a clinic setting uses
the tools (e.g., orchidometer) for measuring testicular
size (Table 3). This is followed by semen analysis,
endocrine assessment of the
hypothalamic-pituitary-testicular axis by blood work, and analysis of testicular biopsy
samples when indicated. Although research on
testicular toxicology has been advanced significantly by the
introduction of in vitro testing systems, the
in vivo tools however, are still essential parts of the risk assessment
process, and they are unlikely to be eliminated
by in vitro models.
Food and Drug Administration (FDA) requirements
for evaluation of reproductive toxicity or
pharmacological testing of a new drug in humans involves a multicenter
placebo controlled dose escalation format. Currently there
is a focus on standardized semen analysis to note any
changes. The studies entail refined statistical analysis
for minimal variability and proper quality control [69].
6.2 In vitro systems
In vitro systems are uniquely suited to investigate
specific cellular and molecular mechanisms in the testis
and thus improve risk assessment [68]. These in
vitro models can be used alone or in combination with each
other to test hypotheses about testicular toxicity. An
original toxicant, its metabolites, the precursors or
selective inhibitors can be individually administered to
isolated cell types to evaluate specific toxicity mechanisms
and to note the interaction of adjacent cell types.
Numerous in vitro model systems are described in the
literature, including Sertoli-germ cell cocultures [70],
Sertoli cell-enriched cultures [71, 72], germ cell-enriched
cultures [73], Leydig cell cultures [31, 70],
Leydig-Sertoli cell cocultures [74], and peritubular and tubular cell
cultures [70, 74]. These in vitro systems are the only
way to directly compare human and animal responses
and to screen a class of compounds for new product
development. Though these in vitro systems are a
valuable adjunct to the in vivo test system, they do not
replace the in vivo data because they cannot provide all
the facts essential for hazard assessment. Moreover,
certain dynamic changes associated with spermatogenesis are difficult to model
in vitro. For example, the release of elongated spermatids by the Sertoli cells
(spermiation), which is commonly inhibited by boric acid
and methyl chloride, can only be studied at present by
specific in vivo systems.
In the wake of media coverage of possible reproductive health and cancer concerns, a few toxicologists
have questioned whether these adverse health effects can
be attributed to environmental endocrine disruption
[75,76]. Arguments for a demonstrable link between
hormone-disruptive environmental agents and human
reproductive health effects are supported by the fact that many
pesticides and other agents with estrogenic or
anti-androgenic activity operate via hormone receptor mechanisms.
However, in the few studies of suspected weak estrogens,
like the alkylphenols, some 1 000 to 10 000 times or up to
106 times more of the agent is required to bind 50% of the
estrogen receptor than estradiol itself [61]. Of course,
crucial to risk assessment is the need to know how many
receptors must be occupied before activation of a
response can ensue. For some hormones such as human
chorionic gonadotropin (hCG), as little as 0.5% to 5%
receptor occupancy is required for full activation of
response. For other hormones (those that require
protein synthesis for expression of effect), higher levels of
receptor occupancy are needed. Fluctuations of hormone
concentration and receptor activities, by design, absorb
some environmental and physiological challenges to
maintain homeostasis in adults. Only when the equilibrium
control mechanisms are overwhelmed, the deleterious
effects occur. An important question is whether
homeostatic mechanisms are operative in the embryo and fetus.
Some investigators have proposed the use of in
vitro assays to screen for estrogenic or other hormonal
activity [77]. While steroid receptors bound to their ligand
act as transcription factors for gene expression in the
target tissue, simple in vitro screening assays based on
binding to a receptor are not sufficient in themselves for
measuring hormone activity. Binding of ligand to its
specific receptor must be correlated with a physiologic
response.
6.3 Sperm nuclear integrity assessment
Recent attention has focused on assessments of sperm
morphology and physiology as important endpoints in
reproductive toxicology testing [78]. Structural stability
of sperm nuclei varies by species, appears to be enhanced
by the oxidation of protamine sulfhydryl to inter- and
intra-molecular disulfide bonds, and is a function of the
types of protamine present. Chemicals may disrupt the
structural stability of sperm nuclei, which depend upon
their unique packaging either during spermatogenesis or
sperm maturation. Decondensation of an isolated sperm
nucleus in vitro can be induced by exposure to disulfide
reducing agents, and the time taken to induce extensive
decondensation is considered to be inversely proportional
to the stability of the sperm nucleus. Human sperm
decondenses most rapidly, followed by that of the mouse
and of the hamster, while rat sperm nuclei demonstrates
a slower rate of decondensation [79]. Such a sperm
DNA decondensation assay is useful in the evaluation of
some cases of unexplained infertility [80]. Evidence
suggests that damage to human sperm DNA might adversely
affect reproductive outcomes and that the spermatozoa
of infertile men possess substantially more sperm DNA
damage than do the spermatozoa of fertile men [80]. This
is particularly relevant in an era where advanced forms
of assisted reproductive technologies are commonly used
(technologies that often bypass the barriers to natural
selection), because there is some uncertainty regarding
the safety of using DNA-damaged spermatozoa. However,
sperm head morphology has shown low but significant
correlations with the sperm chromatin structure
assay (SCSA) variables [81]. Evaluation of damaged sperm
DNA seems to complement the investigation of factors
affecting male fertility and may prove an efficient
diagnostic tool in the prediction of pregnancy outcome [20].
Other tests, called DNA stability assay or SCSA use
direct evaluation of sperm chromatin integrity and may
provide information about genetic damage to sperm and
predict infertility [82, 83]. A shift in DNA pattern (from
double stranded intact DNA to denatured single stranded)
can be induced by a variety of mutagenic and chemical
agents and evaluated either by DNA flow cytometry
analysis or by sperm chromatin structure assay [84]. A
modified single cell gel electrophoresis (Comet)
assay, which uses a combination of fluorescence intensity measurements
by microscopy and image analysis has been recently
validated [20]. A shift in the DNA pattern can be evaluated by
acridine orange staining, where double-stranded DNA is
stained green and single stranded DNA is stained red. The
data is expressed as DNA Fragmentation Index
(DFI).
DNA flow cytometry is a very useful tool that
permits rapid, objective assessment of a large number of
cells, but may not be readily available. Comet assay,
when combined with centrifugal elutriation, can provide
a useful in vitro model to study differences in
metabolism and the susceptibility of different testicular cell types
to DNA damaging compounds. Thus, new findings through these systems should lead to greater knowledge
about effects and mechanism(s) of a chemical or class
of chemicals involved in testicular toxicity.
7 Summary
Some authorities suggest that the human race is
experiencing increased incidences of developmental,
reproductive, and carcinogenic effects. Some believe
these adverse effects may be caused by environmental
chemicals acting to disrupt the endocrine system that
regulates many of these processes. This is supported by
observations of similar effects in aquatic and wildlife
species. However, the hypothesis that the reported
increased incidence of human cancers, reproductive
abnormalities, and infertility can be attributed to an
endocrine disruption phenomenon is called into question
for several reasons.
First, the secretion and elimination of hormones are
highly regulated by the body, and mechanisms for
controlling modest fluctuations of hormones are in place via
negative feedback control of hormone concentrations.
Therefore, minor increases of environmental hormones
following dietary absorption and liver detoxification of
these xenobiotics may be inconsequential in disrupting
normal endocrine homeostasis. Second, low ambient
concentrations of chemicals along with low affinity
binding of purported xenobiotics to target receptors
probably are insufficient to activate an adverse response in
adults. Whether the fetus and the young are capable of
regulating minor changes to the endocrine milieu is
uncertain. Finally, the full data are not available for
combinations of chemicals that may be able to affect
endocrine function. At the same time, in the case of
environmental estrogens acting as endocrine disruptors,
it is known that competition for binding sites by
antiestrogens in the environment may moderate the
estrogenic effects of some chemicals. Clearly, more research
to fill in the data gaps is needed.
With few exceptions (e.g., diethylstllbestrol
[DES]), a causal relationship between exposure to a specific
environmental agent and an adverse effect on human health
operating via an endocrine disruption mechanism has not been
established. Short-term screening studies can be
developed and validated in an effort to elucidate the mechanism.
Through controlled dose-response studies, it appears that
these compounds (e.g., alkyl phenol ethylates and their
degradation products, chlorinated dibenzodioxins and difurans,
and PCBs), can induce irreversible induction of male sex
characteristics on females (imposex), which leadd to sterility.
In conclusion, a variety of external and internal
factors can induce testicular toxicity leading to poor sperm
quality and male factor infertility. Unfortunately, several
of these influences (e.g., glandular infection,
environmental toxicants, nutritional deficiencies, aging, ischemia,
and oxidative stress) disrupt the hormonal milieu and have
been underestimated. Partial androgen insensitivity mainly
due to an androgen-to-estrogen imbalance may
contribute to lowered sperm production. The role of chronic
inflammation on the reproductive organs is not completely understood as it may be asymptomatic and
difficult to diagnose. There is a need to characterize all of the
factors involved and to develop reliable animal
models of testicular disease. No major advances have been made
in the medical management of poor sperm quality. The
application of assisted reproductive techniques such as
ICSI to male infertility, regardless of cause, does not
necessarily treat the cause and may inadvertently pass
on adverse genetic consequences. Clinicians should
always attempt to identify the etiology of a possible
testicular toxicity, assess the degree of risk to the patient
being evaluated for infertility, and initiate a plan to
control and prevent exposure to others once an association
between occupation/toxicant and infertility has been
established.
References
1 Brake A, Krause W. Decreasing quality of semen. BMJ 1992;
305: 1498.
2 Lewis SE, Aitken RJ. DNA damage to spermatozoa has impacts on
fertilization and pregnancy. Cell Tissue Res
2005; 322: 33_41.
3 Olsen GW, Bodner KM, Ramlow JM, Ross CE, Lipshultz LI.
Have sperm counts been reduced 50 percent in 50 years? A
statistical model revisited. Fertil Steril 1995; 63: 887_93.
4 Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH.
Semen analyses in 1 283 men from the United States over a 25-year
period: No decline in quality. Fertil Steril 1996; 65: 1009_14.
5 Parvinen M, Lahdetie J, Parvinen LM. Toxic and mutagenic
influences on spermatogenesis. Arch Toxicol Suppl 1984;
7: 128_39.
6 Niederberger C. Exposure to persistent organochlorine
pollutants associates with human sperm Y:X chromosome ratio. Hum
Reprod 2005; 20: 1903_9.
7 Guillette LJ Jr, Gross TS, Masson GR, Matter JM, Percival HF,
Woodward AR. Developmental abnormalities of the gonad and
abnormal sex hormone concentrations in juvenile alligators from
contaminated and control lakes in Florida. Environ Health
Perspect 1994; 102: 680_8.
8 Kavlock RJ, Perreault SD. Multiple chemical exposure and risks
of adverse reproductive function and outcome. In:
Toxicological of Chemical Mixtures: From Real Life Examples to
Mechanisms of Toxicology Interactions. Yang RS, editor. Academic
Press: Orlando. 1994; p245_97.
9 Sokol RZ. Hormonal effects of lead acetate in the male rat:
mechanism of action. Biol Reprod 1987; 37: 1135_8.
10 Sikka SC. Gonadotoxicity. In: Male Infertility and Sexual
Dysfunction. Hellstrom WJ, editor. Springer-Veerlag, New York.
1997; p292_306.
11 Lamb DJ. Hormonal disruptors and male infertility: are men at
serious risk? Regul Toxicol Pharmacol 1997; 26: 30_3.
12 Cheek AO, McLachlan JA. Environmental hormones and the
male reproductive system. J Androl 1998; 19: 5_10.
13 McLachlan JA, Arnold SF. Environmental estrogens. Amer Sci
1996; 84: 452_61.
14 Colborn T, vomSaal FS, Soto AM. Developmental effects of
endocrine-disrupting chemicals in wildlife and humans. Env
Health Prospect 1993; 1101: 378_84.
15 Sikka SC, Nigun G. Reproductive Toxicity of Organophosphate
and Carbamate Pesticides. In: Toxicology of Organophosphate
and Carbamate Compounds. Gupta RC, editor. Elsevier
Academic Press: New York. 2005; Chapter 32, p447_62.
16 Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE Jr.
Environmental hormone disruptors: evidence that vinclozolin
developmental toxicity is mediated by antiandrogenic metabolites.
Toxicol Appl Pharm 1994; 126: 276_85.
17 Sharpe RM, Skakkebaek NE. Are estrogens involved in falling
sperm counts and disorders of the male reproductive tract?
Lancet 1993; 351: 1392_5.
18 Working PK. Male reproductive toxicology: comparison of the
human to animal models. Environ Health Prospect 1988; 77: 37_44.
19 Sokol RZ. Toxicants and infertility: identification and prevention. In:
Management of impotence and infertility. Whitehead ED, Nagler
HM, editors. JB Lippincott Company: Philadelphia. 1994; p380_9.
20 Angelopoulou R, Plastira K, Msaouel P. Spermatozoal sensitive
biomarkers to defective protaminosis and fragmented
DNA. Reprod Biol Endocrinol 2007; 5: 36.
21 Mandl AM. The radiosensitivity of germ cells. Biol Rev Camb
Philos Soc 1964; 39: 288_371.
22 Whorton D, Krauss RM, Marshall S, Milby TH. Infertility in
male pesticide workers. Lancet 1977; 2: 1259_61.
23 Mattison DR. The mechanisms of action of reproductive toxins.
Am J Ind Med 1983; 4: 65_79.
24 Potashnik G, Yanai-Inbar I. Dibromochloropropane (DBCP):
an 8-year reevaluation of testicular function and reproductive
performance. Fertil Steril 1987; 47: 317_23.
25 Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA,
Wilson EM. Persistent DDT metabolite p,p'-DDE is a potent
androgen receptor antagonist. Nature 1995; 375: 581_5.
26 Vine MF, Tse CK, Hu P, Truong KY. Cigarette smoking and
semen quality. Fertil Steril 1996; 65: 835_42.
27 Schrader SM. Principles of male reproductive toxicology. In:
Environmental Medicine. Brooks SM, Gochfeld M, editors. St.
Louis: Mosby Press. 1995; p95_100.
28 Gilfillan SC. Lead poisoning and the fall of Rome. J Occup Med
1965; 7: 53_60.
29 Lancranjan I, Popescu HI, Gavanescu O, Klepsch I, Serbanescu
M. Reproductive ability of workmen occupationally exposed to
lead. Arch Environ Health 1975; 30: 396_401.
30 Winder C. Reproductive and chromosomal effects of occupational
exposure to lead in males. Reprod Toxicol 1989; 3: 221_33.
31 Ewing LL, Zirkin BR, Chubb C. Assessment of testicular
testosterone production and Leydig cell structure. Environ Health
Perspect 1981; 38: 19_27.
32 Foster WG, McMahon A,Young-Lai EV, Hughes EG, Rice DC.
Reproductive endocrine effects of chronic lead exposure in the
male cynomolgus monkey. Reprod Toxicol 1993; 7: 203_9.
33 Braunstein GD, Dahlgren J, Loriaux DO. Hypogonadism in
chronically lead poisoned men. Infertility 1978; 1: 33_51.
34 Weir RJ Jr, Fisher RS. Toxicological studies on borox and boric
acid. Toxicol Appl Pharmacol 1972; 23: 351_64.
35 Friberg L, Piscator M, Nordberg GF. Cadmium in the environment,
2nd edition. Cleveland: CRC Press Inc.. 1974; p37_53.
36 King LM, Anderson MG, Sikka SC, George WJ. Murine strain
differences in cadmium-induced testicular toxicity. Arch Toxical
1998; 72: 650_5.
37 Snow ET. Metal carcinogenesis: mechanistic implications.
Pharmacol Ther 1992; 53: 31_65.
38 Sikka SC, Rajasekaran M, Hellstrom WJ. Role of oxidative stress
and antioxidants in male infertility. J Androl 1995; 16:464_8.
39 Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman
JS. Peroxynitroite, a cloaked oxidant formed by nitric oxide and
superoxide. Chem Res Toxicol 1992; 5: 834_42.
40 Rosselli M, Dubey RK, Imthurn B, Macase E, Keller PJ. Effects
of nitric oxide on human spermatozoa: evidence that nitric
oxide decreases sperm motility and induces sperm toxicity. Hum
Reprod 1995; 10: 1786_90.
41 Oats RD, Lipshultz LI. Fertility and testicular function in
patients after chemotherapy and radiotherapy. In: Advances in
Urology, vol 2. Lytton B, editor. Chicago: Mosby Year Book.
1989; p55_83.
42 Rowley MJ, Leach DR, Warner GA, Heller CG. Effects of graded
doses of ionizing radiation on the human testis. Radiat Res 1974;
59: 665_78.
43 Ogilvy-Stuart AL, Shalet SM. Effect of radiation on the Human
reproductive system. Environ Health Perspect 1993; 101 Suppl
2: 109_16.
44 Knuth UA, Maniera H, Nieschlag E. Anabolic steroids and semen
parameters in bodybuilders. Fertil Steril 1989; 52: 1041_7.
45 Jarow JP, Lipshultz LI. Anabolic
steroid-induced hypogonadotropic hypogonadism. Am J Sports Med 1990; 18: 429_31.
46 Ericsson RJ, Baker VF. Binding of tetracycline to mammalian
spermatozoa. Nature 1967; 214: 403_4.
47 Schlegel PN, Chang TS, Maeshall FF. Antibiotics: potential
hazards to male fertility. Fertil Steril 1991; 55: 235_42.
48 Shalet SM. Effects of cancer chemotherapy on testicular
function of patients. Cancer Treat Rev 1980; 7: 41_152.
49 Spitz S. The histological effects of nitrogen mustards on human
tumors and tissues. Cancer 1948; 1: 383_8.
50 Meistrich ML. Quantitative correlation between testicular stem
cell survival, sperm production, and fertility in mouse after
treatment with different cytotoxic agents. J Androl 1982; 3: 58_68.
51 Qiu J, Hales BF, Robaire B. Adverse effects of
cyclophosphamide on progeny outcome can be mediated through
post-testicular mechanisms in the rat. Biol Reprod 1992; 46: 926_31.
52 Trasler JM, Hales BF, Robaire B. A time course study of chronic
paternal cyclophosphamide treatment of rats: effects on
pregnancy outcome and the male reproductive and hematologic
systems. Biol Reprod 1987; 37: 317_26.
53 Sherins RJ, DeVita VT Jr. Effect of drug treatment for
lymphoma on male reproductive capacity. Ann Intern Med
1973;79: 216_20.
54 Parvinen M, Lahdetie J, Parvinen LM. Toxic and mutagenic
influences on spermatogenesis. Arch Toxicol Suppl 1984;
7: 128_39.
55 Manavathi B, Kumar R. Steering estrogen signals from the plasma
membrane to the nucleus: two sides of the coin. J Cell Physiol
2006; 207: 594_604.
56 Wilson CA, Leigh AJ, Chapman AJ. Gonadotrophin glycosylation
and function. J Endocrinol 1990; 125: 3_14.
57 Cooper RL, Goldman JM, Rehnberg GL, McElroy WK, Hein JF.
Effects of metal cations on pituitary hormone secretion
in vitro. J Biochem Toxicol 1987; 2: 241_9.
58 Bulger WH, Nuccitelli RM, Kupfer D. Studies on the
in vivo and in vitro estrogenic activities of methoxychlor and its metabolites
role of hepatic mono-oxygenase in methoxychlor activation.
Biochem Pharmacol 1978; 27: 2417_23.
59 Welch RM, Levin W, Kuntzman R, Jocobson M, Conney AH.
Effect of halogenated hydrocarbon insecticides on the
metabolism and uterotropic action of estrogens in rats and mice. Toxicol
Appl Pharmacol 1971; 19: 234_46.
60 Mueller GC, Kim UH. Displacement of estradiol from estrogen
receptors by simple alkyl phenols. Endocrinology 1978; 102:
1429_35.
61 White R, Jobling S, Hoare SA, Sumpter JP, Parker MG.
Environmentally persistent alkylphenolic compounds are estrogenic.
Endocrinology 1994; 135: 175_82.
62 O'Brian CA, Liskamp RM, Solomon DH and Weinstein IB. Inhibition
of protein kinase C by tamoxifen. Cancer Res
1985; 45: 2462_5.
63 Safe S, Astroff B, Harris M, Zacharewski T, Dickerson R, Romkes
M, et al. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) and
related compounds as antiestrogens; characterization and
mechanism of action. Pharmacol Toxicol 1991; 69: 400_9.
64 Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA.
Apparent hydroxyl radical production by peroxynitrite:
implications for endothelial injury from nitric oxide and superoxide.
Proc Natl Acad Sci U S A 1990; 87: 1620_4.
65 Gagnon C, Iwasaki A, De Lamirande E, Kovalski N. Reactive
oxygen species and human spermatozoa. Ann N Y Acad Sci
1991; 637: 436_44.
66 Aitken RJ, Clarkson JS. Cellular basis of defective sperm
function and its association with the genesis of reactive oxygen
species by human spermatozoa. J Reprod Fertil 1987; 81: 459_69.
67 Alvarez JG, Touchstone JC, Blasco L, Storey BT. Spontaneous lipid
peroxidation and production of hydrogen peroxide and superoxide
in human spermatozoa. Superoxide dismutase as major enzyme
protectant against oxygen toxicity. J Androl 1987; 8: 338_48.
68 Lamb JC 4th, Chapin RE. Testicular and germ cell toxicity:
in vitro approaches. Reprod Toxicol 1993; 7 (Suppl 1): 17_22.
69 Hellstrom WJ, Overstreet JW, Sikka SC, Denne J, Ahuja S, Hoover
AM, et al. Semen and sperm reference ranges for men 45 years of
age and older. J Androl 2006; 27: 421_8.
70 Gray TJ. Application of in vitro systems in male reproductive
toxicology. In: Physiology and toxicology of male reproduction.
Lamb JC 4th, Foster PM, editors. Academic Press: California.
1988; p250_3.
71 Chapin RE, Phelps JL, Somkuti SG, Heindel JJ. The interaction of
Sertoli and Leydig cells in the testicular toxicity of tri-o-cresyl
phosphate. Toxicol Appl Pharmacol 1990; 104: 483_95.
72 Steinberger A, Clinton JP. Two-compartment cultures of Sertoli
cells-Applications in testicular toxicology. In: Methods in
Toxicology (part A), Male Reproductive Toxicology. Chapin RE,
Heindel JJ, editors. Academic Press: New York. 1993; p230_45.
73 Foster PM, Lloyd SC, Prout MS. Toxicity and metabolism of
1,3-dinitrobenzene in rat testicular cell cultures. Toxicol
In vitro 1987; 1: 31_7.
74 Chapin RE, Phelps JL, Somkuti SG, Heindel JJ, Burka LT. The
interaction of Sertoli and Leydig cells in the testicular toxicity of
tri-o-cresyl phosphate. Toxicol Appl Pharmacol 1990; 104: 483_95.
75 Raloff J. The gender benders. Are environmental "hormones"
emasculating wildlife? Science News, 145:24-27, 1994.
76 Stone R. Environmental estrogens stir debate. Science
1994;265: 308_10.
77 Soto AM, Lin TM, Justicia H, Silvia RM, Sonenschein C. An "in
culture" bioasay to assess the estrogenicity of xenobiotics
(E-Screen). In: Chemically Induced Alterations in Sexual and
Functional Development: The Wildlife/Human Connection.
Colborn T, Clements C, editors. Princeton Scientific Publishing
Co., Inc.: Princeton. 1992; p295_309.
78 Darney SP: In vitro assessment of gamete integrity. In
In vitro toxicology: Mechanisms and new toxicology- Alternative
methods in toxicology, Vol 8. Goldberg AM, editor. Ann Liebert, Inc.:
New York. 1991; p63_75.
79 Perrault SD, Barbee RR, Elstein KH, Zucker RM, Keeler CL.
Interspecies differences in the stability of mammalian sperm
nuclei assessed in vivo by sperm microinjection and
in vitro by flow cytometry. Biol Reprod 1988; 39: 157_67.
80 Zini A, Libman J. Sperm DNA damage: clinical significance in
the era of assisted reproduction. CMAJ 1006; 175: 495_500.
81 Boe-Hansen GB, Fedder J, Ersbøll AK, Christensen P. The sperm
chromatin structure assay as a diagnostic tool in the human
fertility clinic. Hum Reprod 2006; 21: 1576_82.
82 Evenson DP. Flow cytometry evaluation of male germ cells, In:
Flow Cytometry: Advanced Research and Clinical Applications,
vol 1, Yen A, editor. CRC Press: Boca Raton FL. 1989; p218_46.
83 Evenson DP, Jost LK, Baer RK, Turner TW, Schrader SM.
Individuality of DNA denaturation patterns in human sperm as
measured by the sperm chromatin structure assay. Reprod Toxicol
1991; 5: 115_25.
84 Brown DB, Hayes EJ, Uchida T, Nagamani M. Some cases of
human male infertility are explained by abnormal
in vitro human sperm activation. Fertil Steril 1995; 64: 612_22.
|